Delivery Order SPE2DB25D3002-SPE2DB25FLQLC

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,371.23, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,785.17, is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a Firm Fixed Price arrangement with a completion date of February 26, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,511.97, is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a firm fixed-price delivery order that has a completion date of December 6, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,476.11, is for the provision of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a firm fixed price delivery order, with an ultimate completion date of January 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,742.61, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. This award is not associated with a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,690.44, is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of March 6, 2025 and is a firm fixed-price contract type. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.13, is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,792.68, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a firm fixed price pricing type and a period of performance through January 19, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,664.52, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a firm fixed price pricing type and has an ultimate completion date of January 9, 2025. This award is not associated with a set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,225.50, is for the provision of BRILINTA 90 MG TABLET 60S, a medication used to treat cardiovascular conditions. The contract has an ultimate completion date of June 10, 2024 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type....
  • SPE2DB25D3002
    Indefinite Delivery Contract
  • SPE2DB25D3002-SPE2DB25FLQLC
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,014.44, is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.

Generated 7/14/25, 10:51 AM